Business, Spoken

US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine

Business, Spoken

Show Notes

As fears of a pandemic mount, the biotech company’s mRNA vaccine trial is set to release Phase 1/2 results later this year, with a larger Phase 3 trial expected to begin in 2025.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

More from Business, Spoken

Oct 23, 2026

Listen to more of The Big Story here: ⁠⁠⁠⁠http://swap.fm/l/wi-bigstorypod-feeddrop

Oct 21, 2026

Listen to more of The Big Story here: ⁠⁠⁠⁠http://swap.fm/l/wi-bigstorypod-feeddrop

Oct 19, 2026

Including what Elizabeth Holmes said to him last week. A WIRED exclusive interview with the comic auteur, as his first feature film hits theaters.

Oct 18, 2026

Listen to more of The Big Story here: ⁠⁠⁠⁠http://swap.fm/l/wi-bigstorypod-feeddrop

Oct 16, 2026

Listen to more of The Big Story here: ⁠⁠⁠⁠http://swap.fm/l/wi-bigstorypod-feeddrop

See all episodes →